IVIG Boya: Safety, Efficacy, and Pharmacokinetics | MicrobiomeTrials← Back to trialsNCT06150833
IVIG Boya: Safety, Efficacy, and Pharmacokinetics
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2028-09
Enrollment target: 50 participants Other microbiome trials you might be interested in
HIV-1-infection
The goal of this clinical study is to provide continued access to the study drug(s) to children and adolescents with hum…
Buenos Aires, ArgentinaEst. completion Mar 2034
HIV InfectionsDrug UseOpioid UseOpioid-use Disorder
The purpose of this study is to determine the efficacy of using a mobile health delivery unit ("mobile unit") to deliver…
Los Angeles, United StatesCompleted Dec 17, 2024
Cystic FibrosisPseudohypoaldosteronismNontuberculous Mycobacterial InfectionChronic Granulomatous DiseasePrimary Ciliary Dyskinesia
Healthy volunteers and patients with diseases that involve problems clearing mucus from the lungs will be examined and t…
Bethesda, United StatesCompleted Oct 1, 2012